• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

终末期糖尿病肾病中老年患者的肠道微生物群多样性

Gut microbiota diversity in middle-aged and elderly patients with end-stage diabetic kidney disease.

作者信息

Chen Rongping, Zhu Dan, Yang Rui, Wu Zezhen, Xu Ningning, Chen Fengwu, Zhang Shuo, Chen Hong, Li Ming, Hou Kaijian

机构信息

School of Laboratory Medical and Biotechnology, Southern Medical University, Guangzhou, China.

Department of Endocrine and Metabolic Diseases, Longhu Hospital, The First Affiliated Hospital of Shantou University Medical College, Shantou, China.

出版信息

Ann Transl Med. 2022 Jul;10(13):750. doi: 10.21037/atm-22-2926.

DOI:10.21037/atm-22-2926
PMID:35957707
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9358493/
Abstract

BACKGROUND

Diabetic kidney disease (DKD) is the most common cause of end-stage renal disease (ESRD), but the mechanism between DKD and ESRD remains unclear. Some experts have put forward the "microbial-centered ESRD development theory", believing that the bacterial load caused by gut microecological imbalance and uremia toxin transfer are the core pathogenic links. The purpose of this study was to analyze the genomic characteristics of gut microbiota in patients with ESRD, specifically DKD or non-diabetic kidney disease (NDKD).

METHODS

In this cross-sectional study, patients with ESRD were recruited in a community, including 22 DKD patients and 22 NDKD patients matched using gender and age. Fecal samples of patients were collected for 16S rDNA sequencing and gut microbiota analysis. The distribution structure, diversity, and abundance of microflora in DKD patients were analyzed by constructing species evolutionary trees and analyzing alpha diversity, beta diversity, and linear discriminant analysis effect size (LEfSe).

RESULTS

The results of our study showed that there were statistically significant differences in the richness and species of gut microbiota at the total level between DKD patients and NDKD patients. The analysis of genus level between the two groups showed significant differences in 16 bacterial genera. Among them, Oscillibacter, Bilophila, UBA1819, Ruminococcaceae UCG-004, Anaerotruncus, Ruminococcaceae, and Ruminococcaceae NK4A214 bacteria in DKD patients were higher than those in NDKD patients.

CONCLUSIONS

16S rDNA sequencing technology was used in this study to analyze the characteristics of intestinal flora in ESRD patients with or without diabetes. We found that there was a significant difference in the intestinal flora of ESRD patients caused by DKD and NDKD, suggesting that these may be potential causative bacteria for the development of ERSD in DKD patients.

摘要

背景

糖尿病肾病(DKD)是终末期肾病(ESRD)最常见的病因,但DKD与ESRD之间的机制仍不清楚。一些专家提出了“以微生物为中心的ESRD发展理论”,认为肠道微生态失衡导致的细菌负荷和尿毒症毒素转移是核心致病环节。本研究的目的是分析ESRD患者,特别是DKD或非糖尿病肾病(NDKD)患者肠道微生物群的基因组特征。

方法

在本横断面研究中,在一个社区招募ESRD患者,包括22例DKD患者和22例按性别和年龄匹配的NDKD患者。收集患者的粪便样本进行16S rDNA测序和肠道微生物群分析。通过构建物种进化树和分析α多样性、β多样性及线性判别分析效应大小(LEfSe),分析DKD患者微生物群的分布结构、多样性和丰度。

结果

我们的研究结果表明,DKD患者和NDKD患者在肠道微生物群的丰富度和种类总体水平上存在统计学显著差异。两组属水平分析显示16个细菌属存在显著差异。其中,DKD患者中的颤杆菌属、嗜胆菌属、UBA1819、瘤胃球菌科UCG - 004、厌氧短杆菌属、瘤胃球菌科和瘤胃球菌科NK4A214细菌高于NDKD患者。

结论

本研究采用16S rDNA测序技术分析了有或无糖尿病的ESRD患者的肠道菌群特征。我们发现,由DKD和NDKD引起的ESRD患者肠道菌群存在显著差异,提示这些可能是DKD患者发生ERSD的潜在致病菌。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f48a/9358493/a5c26e217d85/atm-10-13-750-f9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f48a/9358493/c015fd644253/atm-10-13-750-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f48a/9358493/7bd122a8cf3c/atm-10-13-750-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f48a/9358493/afbe88c1e14c/atm-10-13-750-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f48a/9358493/aac9310d54d4/atm-10-13-750-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f48a/9358493/451d726dd300/atm-10-13-750-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f48a/9358493/66bf7cb5b2f8/atm-10-13-750-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f48a/9358493/819e2fbe669f/atm-10-13-750-f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f48a/9358493/9cad68585279/atm-10-13-750-f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f48a/9358493/a5c26e217d85/atm-10-13-750-f9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f48a/9358493/c015fd644253/atm-10-13-750-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f48a/9358493/7bd122a8cf3c/atm-10-13-750-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f48a/9358493/afbe88c1e14c/atm-10-13-750-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f48a/9358493/aac9310d54d4/atm-10-13-750-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f48a/9358493/451d726dd300/atm-10-13-750-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f48a/9358493/66bf7cb5b2f8/atm-10-13-750-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f48a/9358493/819e2fbe669f/atm-10-13-750-f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f48a/9358493/9cad68585279/atm-10-13-750-f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f48a/9358493/a5c26e217d85/atm-10-13-750-f9.jpg

相似文献

1
Gut microbiota diversity in middle-aged and elderly patients with end-stage diabetic kidney disease.终末期糖尿病肾病中老年患者的肠道微生物群多样性
Ann Transl Med. 2022 Jul;10(13):750. doi: 10.21037/atm-22-2926.
2
Gut microbiota profiling reflects the renal dysfunction and psychological distress in patients with diabetic kidney disease.肠道微生物组谱反映了糖尿病肾病患者的肾功能障碍和心理困扰。
Front Endocrinol (Lausanne). 2024 Jul 15;15:1410295. doi: 10.3389/fendo.2024.1410295. eCollection 2024.
3
A systematic review and meta-analysis of gut microbiota in diabetic kidney disease: Comparisons with diabetes mellitus, non-diabetic kidney disease, and healthy individuals.糖尿病肾病患者肠道微生物组的系统评价和荟萃分析:与糖尿病、非糖尿病肾病和健康个体的比较。
Front Endocrinol (Lausanne). 2022 Oct 20;13:1018093. doi: 10.3389/fendo.2022.1018093. eCollection 2022.
4
The Role of Gut Microbiota and Microbiota-Related Serum Metabolites in the Progression of Diabetic Kidney Disease.肠道微生物群和微生物群相关血清代谢产物在糖尿病肾病进展中的作用
Front Pharmacol. 2021 Nov 24;12:757508. doi: 10.3389/fphar.2021.757508. eCollection 2021.
5
Non-Diabetic Kidney Disease in Type 2 Diabetic Patients: Prevalence, Clinical Predictors and Outcomes.2型糖尿病患者中的非糖尿病肾病:患病率、临床预测因素及预后
Kidney Blood Press Res. 2017;42(5):886-893. doi: 10.1159/000484538. Epub 2017 Nov 1.
6
Non-diabetic Kidney Disease in Diabetic Population: A Single-Center Study From South India.糖尿病患者中的非糖尿病肾病:来自印度南部的单中心研究
Cureus. 2022 Apr 6;14(4):e23899. doi: 10.7759/cureus.23899. eCollection 2022 Apr.
7
Clinical Predictors of Nondiabetic Kidney Disease in Patients with Diabetes: A Single-Center Study.糖尿病患者非糖尿病性肾脏疾病的临床预测因素:一项单中心研究。
Int J Nephrol. 2021 Jul 12;2021:9999621. doi: 10.1155/2021/9999621. eCollection 2021.
8
Specific gut microbiome and metabolome changes in patients with continuous ambulatory peritoneal dialysis and comparison between patients with different dialysis vintages.持续性非卧床腹膜透析患者特定肠道微生物群和代谢组的变化以及不同透析龄患者之间的比较。
Front Med (Lausanne). 2024 Jan 5;10:1302352. doi: 10.3389/fmed.2023.1302352. eCollection 2023.
9
The Specific Alteration of Gut Microbiota in Diabetic Kidney Diseases-A Systematic Review and Meta-Analysis.糖尿病肾病中肠道微生物组的特定改变——系统评价和荟萃分析。
Front Immunol. 2022 Jun 17;13:908219. doi: 10.3389/fimmu.2022.908219. eCollection 2022.
10
Compositional Alterations of Gut Microbiota in Patients with Diabetic Kidney Disease and Type 2 Diabetes Mellitus.糖尿病肾病和2型糖尿病患者肠道微生物群的组成改变
Diabetes Metab Syndr Obes. 2022 Mar 6;15:755-765. doi: 10.2147/DMSO.S347805. eCollection 2022.

引用本文的文献

1
Beyond Infection: How Antimicrobial Therapies Influence the Urinary Microbiome and Stone Disease.超越感染:抗菌疗法如何影响泌尿微生物群和结石病
Pharmaceuticals (Basel). 2025 Jul 12;18(7):1038. doi: 10.3390/ph18071038.
2
An Exploration of the Relationship Between Gut Virome and Cardiovascular Disease: A Comprehensive Review.肠道病毒组与心血管疾病关系的探索:一项综述
Rev Cardiovasc Med. 2025 Jun 24;26(6):36386. doi: 10.31083/RCM36386. eCollection 2025 Jun.
3
Therapeutic targeting of PRSS3 to alleviate kidney damage in DKD.

本文引用的文献

1
Gut microbiota and diabetic kidney diseases: Pathogenesis and therapeutic perspectives.肠道微生物群与糖尿病肾病:发病机制及治疗前景
World J Diabetes. 2022 Apr 15;13(4):308-318. doi: 10.4239/wjd.v13.i4.308.
2
Microbiota in health and diseases.肠道菌群与健康和疾病。
Signal Transduct Target Ther. 2022 Apr 23;7(1):135. doi: 10.1038/s41392-022-00974-4.
3
The Role of Gut Microbiota and Microbiota-Related Serum Metabolites in the Progression of Diabetic Kidney Disease.肠道微生物群和微生物群相关血清代谢产物在糖尿病肾病进展中的作用
靶向PRSS3进行治疗以减轻糖尿病肾病中的肾损伤。
Cell Biol Toxicol. 2025 Jun 26;41(1):108. doi: 10.1007/s10565-025-10060-4.
4
The Gut Microbiota Metabolite Butyrate Modulates Acute Stress-Induced Ferroptosis in the Prefrontal Cortex via the Gut-Brain Axis.肠道微生物群代谢产物丁酸通过肠-脑轴调节急性应激诱导的前额叶皮质铁死亡。
Int J Mol Sci. 2025 Feb 17;26(4):1698. doi: 10.3390/ijms26041698.
5
Research progress of gut microbiome and diabetic nephropathy.肠道微生物群与糖尿病肾病的研究进展
Front Med (Lausanne). 2024 Dec 13;11:1490314. doi: 10.3389/fmed.2024.1490314. eCollection 2024.
6
Integrated Data Mining and Animal Experiments to Investigate the Efficacy and Potential Pharmacological Mechanism of a Traditional Tibetan Functional Food . in Hyperuricemia.整合数据挖掘与动物实验以探究一种传统藏药功能性食品治疗高尿酸血症的疗效及潜在药理机制
J Inflamm Res. 2024 Dec 17;17:11111-11128. doi: 10.2147/JIR.S484987. eCollection 2024.
7
Treatment with Gac Fruit Extract and Probiotics Reduces Serum Trimethylamine N-Oxide in Chronic Kidney Disease Rats.番石榴叶提取物和益生菌联合治疗可降低慢性肾脏病大鼠的血清三甲胺 N-氧化物水平。
Nutrients. 2024 Sep 5;16(17):2997. doi: 10.3390/nu16172997.
8
Guild-level signature of gut microbiome for diabetic kidney disease.糖尿病肾病肠道微生物群的群落水平特征
mBio. 2024 Jul 17;15(7):e0073524. doi: 10.1128/mbio.00735-24. Epub 2024 May 31.
9
Role of Gut Microbiota, Immune Imbalance, and Allostatic Load in the Occurrence and Development of Diabetic Kidney Disease.肠道微生物群、免疫失衡和全身适应负荷在糖尿病肾病的发生和发展中的作用。
J Diabetes Res. 2023 Dec 6;2023:8871677. doi: 10.1155/2023/8871677. eCollection 2023.
10
Correlation between gut microbiome and cognitive impairment in patients undergoing peritoneal dialysis.肠道微生物组与腹膜透析患者认知障碍的相关性。
BMC Nephrol. 2023 Dec 5;24(1):360. doi: 10.1186/s12882-023-03410-z.
Front Pharmacol. 2021 Nov 24;12:757508. doi: 10.3389/fphar.2021.757508. eCollection 2021.
4
Reconstruction of intestinal microecology of type 2 diabetes by fecal microbiota transplantation: Why and how.粪菌移植重建 2 型糖尿病患者肠道微生态:为何与如何。
Bosn J Basic Med Sci. 2022 Jun 1;22(3):315-325. doi: 10.17305/bjbms.2021.6323.
5
Gut Bacterial Characteristics of Patients With Type 2 Diabetes Mellitus and the Application Potential.2 型糖尿病患者的肠道细菌特征及应用潜力。
Front Immunol. 2021 Aug 12;12:722206. doi: 10.3389/fimmu.2021.722206. eCollection 2021.
6
Impact of Antibiotic Resistance Genes in Gut Microbiome of Patients With Cirrhosis.肝硬化患者肠道微生物组中抗生素耐药基因的影响。
Gastroenterology. 2021 Aug;161(2):508-521.e7. doi: 10.1053/j.gastro.2021.04.013. Epub 2021 Apr 20.
7
Dysbiosis in the Development of Type I Diabetes and Associated Complications: From Mechanisms to Targeted Gut Microbes Manipulation Therapies.肠道菌群失调在 1 型糖尿病及其相关并发症发病机制中的作用:从发病机制到靶向肠道微生物调控治疗。
Int J Mol Sci. 2021 Mar 9;22(5):2763. doi: 10.3390/ijms22052763.
8
Impacts of gut microbiota on gestational diabetes mellitus: a comprehensive review.肠道微生物群对妊娠期糖尿病的影响:全面综述。
Eur J Nutr. 2021 Aug;60(5):2343-2360. doi: 10.1007/s00394-021-02483-6. Epub 2021 Jan 29.
9
Dapagliflozin Modulates the Fecal Microbiota in a Type 2 Diabetic Rat Model.达格列净对2型糖尿病大鼠模型的粪便微生物群有调节作用。
Front Endocrinol (Lausanne). 2020 Nov 17;11:635. doi: 10.3389/fendo.2020.00635. eCollection 2020.
10
Effects of Fecal Microbiota Transplantation on Composition in Mice with CKD.粪便微生物移植对 CKD 小鼠菌群组成的影响。
Toxins (Basel). 2020 Nov 24;12(12):741. doi: 10.3390/toxins12120741.